Clinical Trials Browser

Unknown × Lymphoma, T-Cell × Clear all

NCT04712864 2023-10-03

Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

Phase 1 Unknown

Lymphoma, T-Cell

NCT05852028 2023-05-10

A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

Lymphoma, Lymphoma, T-Cell

NCT05772728 2023-03-16

Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)

Phase NA Unknown

Lymphoma, T-Cell

NCT05731375 2023-02-16

MUSCLE

Lymphoma, B-Cell, Lymphoma, T-Cell

NCT05367856 2022-09-29

Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT03672084 2022-08-02

Allo-HSCT as First-line Consolidation in High-risk PTCL

Lymphoma, T-Cell

NCT05466318 2022-07-25

ChiCGB vs BEAM in High-risk or R/R Lymphomas

Phase 3 Unknown

Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04928105 2022-05-31

Senl-T7 CAR-T Cells for Treatment of Relapsed or Refractory CD7+ Lymphoma

Phase NA Unknown

Lymphoma, T-Cell

NCT05387226 2022-05-24

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

Phase 1 Unknown

Virus Diseases, Lymphoma, T-Cell

NCT04823091 2022-03-16

Anti-CD7 CAR-Engineered T Cells for T Lymphoid Malignancies Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell

NCT05208853 2022-01-26

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma

Phase EARLY_PHASE1 Unknown

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

NCT05059912 2021-09-28

CD7 CAR T-cell for R/R CD7+ T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell

NCT04264078 2021-06-28

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Phase EARLY_PHASE1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04162340 2021-05-19

CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, T-Cell, Lymphoma, T-Cell

NCT04653649 2020-12-04

CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.

Phase 1/2 Unknown

Hodgkin Disease, Lymphoma, T-Cell

NCT03921879 2020-10-23

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Phase 1 Unknown

Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT02533700 2020-03-10

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Phase 2 Unknown

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT03021057 2019-04-17

Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas

Phase 2 Unknown

Lymphoma, T-Cell

NCT01719835 2018-03-15

CHEMO-T

Phase 2 Unknown

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT03044743 2017-05-02

PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

Phase 1/2 Unknown

GastrointestinalHead & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Stomach Neoplasms, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02742727 2016-12-06

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Phase 1/2 Unknown

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Leukemia, Prolymphocytic, T-Cell, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT02938741 2016-10-25

ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01430013 2015-11-04

Trial of Endostar Combined With CHOPT for T Cell Lymphoma

Phase 2 Unknown

Lymphoma, T-Cell

NCT01854112 2014-08-06

Helical Irradiation of Total Skin (HITS) for T Cell Lymphoma

Lymphoma, T-Cell

NCT00725231 2012-05-07

A-CHOP-14

Phase 3 Unknown

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell

NCT01470066 2011-11-11

Clinical Usefulness and Prognostic Significance of Interim 18F-FDG PET/CT for the Treatment of Peripheral T Cell Lymphomas

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT00840385 2010-09-15

FAD

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT00974324 2010-09-15

PTCL

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral